QORVO INC

QRVONASDAQ

🏆 #807 by market capEarnings Nov 2US Equity

$114.17▲ $0.00 (+0.00%)

🌙 After hours$114.65▲ 0.42%Regular close · extended-hours price shown

🔔

Track QRVO

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 0.0%

7d—

14d—

30d▼ 1.8%

ytd▲ 35.1%

1y▲ 17.2%

🏦Market Cap

$10.07B

Mid Cap

📈Revenue Growth (YoY)

-1.1%

Declining

📊Gross Margin

48.2%

Healthy

💵FCF Margin

17.8%

Healthy

⚖️P/S Ratio

2.8x

Cheap

Otter Score

Fair

QORVO INC

QRVO

Analyst Ratings

Price

$114.17

Total

Raised

Lowered

Avg PT

$108.00

H / L

$120 / $96

Institution	Action	Rating	Date		Upside
Citigroup	Reiterated	Neutral	2026-07-29	$113.00	−1.00%
UBS	Reiterated	Neutral	2026-07-29	$96.00	−15.90%
JP Morgan	Reiterated	Neutral	2026-05-06	$90.00	−21.20%
Barclays	Upgraded	Equal Weight → Overweight	2026-04-22	$60.00	−47.40%
Mizuho	Downgraded	Neutral → Underperform	2026-04-20	—	—
Wolfe Research	Downgraded	Outperform → Peer Perform	2026-04-17	$120.00	+5.10%
Piper Sandler	Reiterated	Overweight	2026-01-28	$90.00	−21.20%
Benchmark	Reiterated	Hold	2026-01-28	—	—
Stifel	Reiterated	Hold	2026-01-28	—	—
Susquehanna	Reiterated	Neutral	2026-01-22	$90.00	−21.20%
Loop Capital	Reiterated	Hold	2025-07-30	—	—
Needham	Reiterated	Buy	2025-07-30	$125.00	+9.50%
Morgan Stanley	Upgraded	Equal Weight → Overweight	2025-01-21	$84.00	−26.40%
Goldman Sachs	Reiterated	Neutral	2025-01-10	$99.00	−13.30%
TD Cowen	Reiterated	Hold	2024-10-30	—	—
Craig-Hallum	Reiterated	Buy	2024-10-30	$120.00	+5.10%
B of A Securities	Reiterated	Underperform	2024-10-30	—	—
Exane BNP Paribas	Downgraded	Outperform → Neutral	2024-10-30	—	—
Raymond James	Downgraded	Outperform → Market Perform	2024-10-30	$100.00	−12.40%
Rosenblatt	Reiterated	Neutral	2024-07-31	—	—
BMO Capital	Reiterated	Market Perform	2023-11-03	$105.00	−8.00%
Summit Insights Group	Downgraded	Buy → Hold	2023-11-02	—	—
Wells Fargo	Reiterated	Equal Weight	2023-08-03	$110.00	−3.70%
Cowen & Co.	Reiterated	Market Perform	2023-02-02	$100.00	−12.40%
KGI Securities	Downgraded	Outperform → Neutral	2022-04-01	—	—
Oppenheimer	Downgraded	Outperform → Perform	2022-01-13	—	—
Argus Research	Downgraded	Buy → Hold	2021-11-05	—	—
CFRA	Reiterated	Hold	2020-05-08	$122.00	+6.90%
Canaccord Genuity	Reiterated	Buy	2020-04-14	—	—
Bank of America	Upgraded	Underperform → Buy	2019-12-09	—	—
Keybanc	Downgraded	Overweight → Sector Weight	2019-04-26	—	—
KeyBanc	Downgraded	Overweight → Sector Weight	2019-04-26	—	—
MKM Partners	Reiterated	Buy	2018-11-14	—	—
Nomura	Reiterated	Neutral	2018-11-14	—	—
Nomura Instinet	Downgraded	Buy → Neutral	2018-03-20	—	—
Instinet	Downgraded	Buy → Neutral	2018-03-20	—	—
Northland Capital Markets	Upgraded	Market Perform → Outperform	2018-02-01	—	—
Northland Securities	Upgraded	Market Perform → Outperform	2018-02-01	—	—
DA Davidson	Downgraded	Buy → Neutral	2017-05-04	—	—
Charter Equity	Upgraded	Market Perform → Buy	2017-03-15	—	—
Brean Capital	Reiterated	Buy	2016-05-05	—	—
Pacific Crest	Downgraded	Overweight → Sector Perform	2015-09-28	—	—

Institution

Citigroup

Reiterated · Neutral · 2026-07-29

$113.00

−1.00%

UBS

Reiterated · Neutral · 2026-07-29

$96.00

−15.90%

JP Morgan

Reiterated · Neutral · 2026-05-06

$90.00

−21.20%

Barclays

Upgraded · Equal Weight → Overweight · 2026-04-22

$60.00

−47.40%

Mizuho

Downgraded · Neutral → Underperform · 2026-04-20

—

Wolfe Research

Downgraded · Outperform → Peer Perform · 2026-04-17

$120.00

+5.10%

Piper Sandler

Reiterated · Overweight · 2026-01-28

$90.00

−21.20%

Benchmark

Reiterated · Hold · 2026-01-28

—

Stifel

Reiterated · Hold · 2026-01-28

—

Susquehanna

Reiterated · Neutral · 2026-01-22

$90.00

−21.20%

Loop Capital

Reiterated · Hold · 2025-07-30

—

Needham

Reiterated · Buy · 2025-07-30

$125.00

+9.50%

Morgan Stanley

Upgraded · Equal Weight → Overweight · 2025-01-21

$84.00

−26.40%

Goldman Sachs

Reiterated · Neutral · 2025-01-10

$99.00

−13.30%

TD Cowen

Reiterated · Hold · 2024-10-30

—

Craig-Hallum

Reiterated · Buy · 2024-10-30

$120.00

+5.10%

B of A Securities

Reiterated · Underperform · 2024-10-30

—

Exane BNP Paribas

Downgraded · Outperform → Neutral · 2024-10-30

—

Raymond James

Downgraded · Outperform → Market Perform · 2024-10-30

$100.00

−12.40%

Rosenblatt

Reiterated · Neutral · 2024-07-31

—

BMO Capital

Reiterated · Market Perform · 2023-11-03

$105.00

−8.00%

Summit Insights Group

Downgraded · Buy → Hold · 2023-11-02

—

Wells Fargo

Reiterated · Equal Weight · 2023-08-03

$110.00

−3.70%

Cowen & Co.

Reiterated · Market Perform · 2023-02-02

$100.00

−12.40%

KGI Securities

Downgraded · Outperform → Neutral · 2022-04-01

—

Oppenheimer

Downgraded · Outperform → Perform · 2022-01-13

—

Argus Research

Downgraded · Buy → Hold · 2021-11-05

—

CFRA

Reiterated · Hold · 2020-05-08

$122.00

+6.90%

Canaccord Genuity

Reiterated · Buy · 2020-04-14

—

Bank of America

Upgraded · Underperform → Buy · 2019-12-09

—

Keybanc

Downgraded · Overweight → Sector Weight · 2019-04-26

—

KeyBanc

Downgraded · Overweight → Sector Weight · 2019-04-26

—

MKM Partners

Reiterated · Buy · 2018-11-14

—

Nomura

Reiterated · Neutral · 2018-11-14

—

Nomura Instinet

Downgraded · Buy → Neutral · 2018-03-20

—

Instinet

Downgraded · Buy → Neutral · 2018-03-20

—

Northland Capital Markets

Upgraded · Market Perform → Outperform · 2018-02-01

—

Northland Securities

Upgraded · Market Perform → Outperform · 2018-02-01

—

DA Davidson

Downgraded · Buy → Neutral · 2017-05-04

—

Charter Equity

Upgraded · Market Perform → Buy · 2017-03-15

—

Brean Capital

Reiterated · Buy · 2016-05-05

—

Pacific Crest

Downgraded · Overweight → Sector Perform · 2015-09-28

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space